These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4436520)

  • 1. Reimbursement methods for pharmaceutical service.
    Gagnon JP; Rodowskas CA
    J Am Pharm Assoc; 1974 Dec; 14(12):675-8. PubMed ID: 4436520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug consumption and drug compensation].
    Asbrink A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469311
    [No Abstract]   [Full Text] [Related]  

  • 3. PBS charges.
    Harvey K
    Med J Aust; 1991 Mar; 154(5):364-5. PubMed ID: 2017069
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug benefits in health insurance.
    Muller C
    Int J Health Serv; 1974; 4(1):157-70. PubMed ID: 4829894
    [No Abstract]   [Full Text] [Related]  

  • 5. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 6. Public policy considerations in the pricing of prescription drugs in the United States.
    Rucker TD
    Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons.
    Schicke RK
    Int J Health Serv; 1973; 3(2):223-36. PubMed ID: 4197751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consequences of changing from fixed amount payments to percentage payment of drugs].
    Berg SH; Aasmundstveit O; Saanum DT
    Tidsskr Nor Laegeforen; 1990 Oct; 110(26):3391-4. PubMed ID: 2256066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing contrasting approaches to drug services.
    Johnson RE; Campbell WH
    Med Care; 1974 Jan; 12(1):62-74. PubMed ID: 4811403
    [No Abstract]   [Full Text] [Related]  

  • 10. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care cost control by third party payors: fee schedules and the Sherman Act.
    Kallstrom DW
    Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug economics and the elderly: prescriptions for change.
    Lipton HL
    Bus Health; 1988 Mar; 5(5):8-11. PubMed ID: 10312402
    [No Abstract]   [Full Text] [Related]  

  • 13. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare and the politics of prescription drug pricing.
    Oberlander J
    N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
    [No Abstract]   [Full Text] [Related]  

  • 15. Paying the pharmacist under the British National Health Service.
    Smith MC; Booth TG; Jones I
    Inquiry; 1973 Sep; 10(3):57-64. PubMed ID: 4269731
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Hospital charges for pharmaceutical services.
    Zellmer WA
    Am J Hosp Pharm; 1974 Nov; 31(11):1043. PubMed ID: 4432851
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychiatrists and psychotropic drug costs.
    Sider RC; Rubin RR; Fligsten KE
    Compr Psychiatry; 1976; 17(6):723-33. PubMed ID: 991604
    [No Abstract]   [Full Text] [Related]  

  • 18. 24th annual prescription survey, Albany College of Pharmacy.
    DeNuzzo RV
    Med Mark Media; 1980 Apr; 15(4):17-36. PubMed ID: 10245963
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.